Effect of endoscopic sphincterotomy for suspected sphincter of oddi dysfunction on pain-related disability following cholecystectomy: The EPISOD randomized clinical trial

JAMA

Volumn 311, Issue 20, 2014, Pages 2101-2109

  Cotton, Peter B ^a   Durkalski, Valerie ^a   Romagnuolo, Joseph ^a   Pauls, Qi ^a   Fogel, Evan ^b   Tarnasky, Paul ^c   Aliperti, Giuseppe ^d   Freeman, Martin ^e   Kozarek, Richard ^f   Jamidar, Priya ^g   Wilcox, Mel ^h   Serrano, Jose ⁱ   Brawman Mintzer, Olga ^j   Elta, Grace ^k   Mauldin, Patrick ^a   Thornhill, Andre ^a   Hawes, Robert ^a,l   Wood Williams, April ^a   Orrell, Kyle ^a   Drossman, Douglas ^m   Robuck, Patricia ⁱ   more..

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b INDIANA UNIVERSITY   (United States)

^c Dallas Medical Center   (United States)

^d Midwest Therapeutic Endoscopy Consultants   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f VIRGINIA MASON MEDICAL CENTER   (United States)

^g YALE UNIVERSITY   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁱ NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^j RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^k UNIVERSITY OF MICHIGAN   (United States)

^l FLORIDA HOSPITAL   (United States)

^m UNIVERSITY OF NORTH CAROLINA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; BLEEDING; CHOLECYSTECTOMY; CONTROLLED STUDY; DEATH; DISABILITY; DUODENUM PERFORATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; FEMALE; HUMAN; HYPERTENSION; INTESTINE PRESSURE; MAJOR CLINICAL STUDY; MALE; MANOMETRY; MULTICENTER STUDY; PANCREATITIS; PATIENT SAFETY; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL INFECTION; THERAPY EFFECT; TREATMENT OUTCOME; VATER PAPILLA STENOSIS; VATER PAPILLOTOMY;

ABDOMINAL PAIN; ADULT; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLECYSTECTOMY; FEMALE; HEALTH STATUS; HUMANS; MALE; MANOMETRY; MIDDLE AGED; NARCOTICS; PANCREATITIS; SPHINCTER OF ODDI DYSFUNCTION; SPHINCTEROTOMY, ENDOSCOPIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901589138     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.5220     Document Type: Article

References (40)

1. Duncan CB, Riall TS. Evidence-based current surgical practice: calculous gallbladder disease. J Gastrointest Surg. 2012;16(11):2011-2025.
2. Berger MY, Olde Hartman TC, Bohnen AM. Abdominal symptoms: do they disappear after cholecystectomy? Surg Endosc. 2003;17(11):1723-1728.
3. Behar J, Corazziari E, Guelrud M, Hogan W, Sherman S, Toouli J. Functional gallbladder and sphincter of Oddi disorders. Gastroenterology. 2006;130(5):1498-1509.
4. Sherman S, Lehman GA. Sphincter of Oddi dysfunction: diagnosis and treatment. JOP. 2001;2(6):382-400.
5. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54(4):425-434.
6. Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11 497 procedures over 12 years. Gastrointest Endosc. 2009;70(1):80-88.
7. Cohen S, Bacon BR, Berlin JA, et al. National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc. 2002;56(6):803-809.
8. Petersen BT. An evidence-based review of sphincter of Oddi dysfunction, I: presentations with "objective" biliary findings (types I and II). Gastrointest Endosc. 2004;59(4):525-534.
9. Petersen BT. Sphincter of Oddi dysfunction, II: Evidence-based review of the presentations, with "objective" pancreatic findings (types I and II) and of presumptive type III. Gastrointest Endosc. 2004;59(6):670-687.
10. Sgouros SN, Pereira SP. Systematic review: sphincter of Oddi dysfunction - non-invasive diagnostic methods and long-term outcome after endoscopic sphincterotomy. Aliment Pharmacol Ther. 2006;24(2):237-246.
11. Sherman S, Lehman G, Jamidar P, et al. Efficacy of endoscopic sphincterotomy and surgical sphincteroplasty for patients with sphincter of Oddi dysfunction (SOD); randomized controlled study. Gastrointest Endosc. 1994;40:125A.
12. Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Venu RP. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med. 1989;320(2):82-87.
13. Toouli J, Roberts-Thomson IC, Kellow J, et al. Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. Gut. 2000;46(1):98-102.
14. Pasricha PJ. There is no role for ERCP in unexplained abdominal pain of pancreatic or biliary origin. Gastrointest Endosc. 2002;56(6)(suppl):S267-S272.
15. Cotton PB. ERCP is most dangerous for people who need it least. Gastrointest Endosc. 2001;54(4):535-536.
16. Cotton PB, Durkalski V, Orrell KB, et al. Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction. Gastrointest Endosc. 2010;72(5):986-991.
17. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33, quiz 34-57.
18. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory- II. San Antonio, TX: Psychological Corp; 1996.
19. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370.
20. Leserman J, Li Z, Drossman DA, Toomey TC, Nachman G, Glogau L. Impact of sexual and physical abuse dimensions on health status: development of an abuse severity measure. Psychosom Med. 1997;59(2):152-160.
21. Drossman DA, Leserman J, Li Z, Keefe F, Hu YJ, Toomey TC. Effects of coping on health outcome among women with gastrointestinal disorders. Psychosom Med. 2000;62(3):309-317.
22. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377-1390.
23. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-483.
24. Durkalski V, Stewart W, MacDougall P, et al. Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction. World J Gastroenterol. 2010;16(35):4416-4421.
25. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35(3):549-556.
26. Brawman-Mintzer O, Durkalski V, Wu Q, et al. Psychosocial characteristics and pain burden of patients with suspected sphincter of Oddi dysfunction in the EPISOD multicenter trial. Am J Gastroenterol. 2014;109(3):436-442.
27. Romagnuolo J, Cotton PB, Durkalski V, et al. Can patient and pain characteristics predict manometric sphincter of Oddi dysfunction in patients with clinically suspected sphincter of Oddi dysfunction? Gastrointest Endosc. 2014;79(5):765-772.
28. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383-393.
29. Freeman ML, Gill M, Overby C, Cen YY. Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of oddi dysfunction. J Clin Gastroenterol. 2007;41(1):94-102.
30. Topazian M, Hong-Curtis J, Li J, Wells C. Improved predictors of outcome in postcholecystectomy pain. J Clin Gastroenterol. 2004;38(8):692-696.
31. Luman W, Adams WH, Nixon SN, et al. Incidence of persistent symptoms after laparoscopic cholecystectomy: a prospective study. Gut. 1996;39(6):863-866.
32. Black NA, Thompson E, Sanderson CF; ECHSS Group. European Collaborative Health Services Study Group. Symptoms and health status before and six weeks after open cholecystectomy: a European cohort study. Gut. 1994;35(9):1301-1305.
33. Vetrhus M, Berhane T, Søreide O, Søndenaa K. Pain persists in many patients five years after removal of the gallbladder: observations from two randomized controlled trials of symptomatic, noncomplicated gallstone disease and acute cholecystitis. J Gastrointest Surg. 2005;9(6):826-831.
34. Bar-Meir S, Halpern Z, Bardan E, Gilat T. Frquency of papillary dysfunction among cholecystectomized patients. Hepatology. 1984;4(2):328-330.
35. Bielefeldt K. The rising tide of cholecystectomy for biliary dyskinesia. Aliment Pharmacol Ther. 2013;37(1):98-106.
36. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38(9):1569-1580.
37. Park SH, Watkins JL, Fogel EL, et al. Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram. Gastrointest Endosc. 2003;57(4):483-491.
38. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565-590.
39. Wilcox CM. Exploring the use of sham design: implications for endoscopic research. Gastrointest Endosc. 2008;67(1):123-127.
40. Rana JS, Mannam A, Donnell-Fink L, Gervino EV, Sellke FW, Laham RJ. Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease. Am J Cardiol. 2005;95(12):1456-1459.